Among Swedish DLBCL patients, no difference in clinical features was observed between the CD70 WT and gene‐altered groups (Table S6c), although only a limited number of gene‐altered cases were available for analysis (n = 9). The gene discussed is CD70; the disease is diffuse large B-cell lymphoma.